133 related articles for article (PubMed ID: 12102713)
1. Chemokine responses in schistosomal antigen-elicited granuloma formation.
Chiu BC; Chensue SW
Parasite Immunol; 2002 Jun; 24(6):285-94. PubMed ID: 12102713
[TBL] [Abstract][Full Text] [Related]
2. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses.
Warmington KS; Boring L; Ruth JH; Sonstein J; Hogaboam CM; Curtis JL; Kunkel SL; Charo IR; Chensue SW
Am J Pathol; 1999 May; 154(5):1407-16. PubMed ID: 10329593
[TBL] [Abstract][Full Text] [Related]
3. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice.
Jakubzick C; Wen H; Matsukawa A; Keller M; Kunkel SL; Hogaboam CM
Am J Pathol; 2004 Oct; 165(4):1211-21. PubMed ID: 15466387
[TBL] [Abstract][Full Text] [Related]
4. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.
Freeman CM; Chiu BC; Stolberg VR; Hu J; Zeibecoglou K; Lukacs NW; Lira SA; Kunkel SL; Chensue SW
J Immunol; 2005 Feb; 174(4):1962-70. PubMed ID: 15699124
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of ageing on cytokine and chemokine responses during type-1 (mycobacterial) and type-2 (schistosomal) pulmonary granulomatous inflammation in mice.
Chiu BC; Shang X; Frait KA; Hu JS; Komuniecki E; Miller RA; Chensue SW
Mech Ageing Dev; 2002 Feb; 123(4):313-26. PubMed ID: 11744043
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).
Shang XZ; Chiu BC; Stolberg V; Lukacs NW; Kunkel SL; Murphy HS; Chensue SW
Am J Pathol; 2002 Jul; 161(1):257-66. PubMed ID: 12107110
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation.
Chiu BC; Freeman CM; Stolberg VR; Komuniecki E; Lincoln PM; Kunkel SL; Chensue SW
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):106-16. PubMed ID: 12600821
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks.
Chensue SW; Warmington K; Ruth JH; Lukacs N; Kunkel SL
J Immunol; 1997 Oct; 159(7):3565-73. PubMed ID: 9317156
[TBL] [Abstract][Full Text] [Related]
9. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation.
Qiu B; Frait KA; Reich F; Komuniecki E; Chensue SW
Am J Pathol; 2001 Apr; 158(4):1503-15. PubMed ID: 11290568
[TBL] [Abstract][Full Text] [Related]
10. Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation.
Ruth JH; Lukacs NW; Warmington KS; Polak TJ; Burdick M; Kunkel SL; Strieter RM; Chensue SW
J Immunol; 1998 Oct; 161(8):4276-82. PubMed ID: 9780203
[TBL] [Abstract][Full Text] [Related]
11. CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses.
Freeman CM; Stolberg VR; Chiu BC; Lukacs NW; Kunkel SL; Chensue SW
J Immunol; 2006 Sep; 177(6):4149-58. PubMed ID: 16951380
[TBL] [Abstract][Full Text] [Related]
12. AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation.
Hu JS; Freeman CM; Stolberg VR; Chiu BC; Bridger GJ; Fricker SP; Lukacs NW; Chensue SW
Am J Pathol; 2006 Aug; 169(2):424-32. PubMed ID: 16877345
[TBL] [Abstract][Full Text] [Related]
13. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection.
Fallon PG; Dunne DW
J Immunol; 1999 Apr; 162(7):4122-32. PubMed ID: 10201937
[TBL] [Abstract][Full Text] [Related]
14. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
Hernandez HJ; Wang Y; Stadecker MJ
J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation.
Chensue SW; Warmington KS; Allenspach EJ; Lu B; Gerard C; Kunkel SL; Lukacs NW
J Immunol; 1999 Jul; 163(1):165-73. PubMed ID: 10384113
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 4 and 13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks.
Ruth JH; Warmington KS; Shang X; Lincoln P; Evanoff H; Kunkel SL; Chensue SW
Cytokine; 2000 May; 12(5):432-44. PubMed ID: 10857756
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice.
Lu B; Rutledge BJ; Gu L; Fiorillo J; Lukacs NW; Kunkel SL; North R; Gerard C; Rollins BJ
J Exp Med; 1998 Feb; 187(4):601-8. PubMed ID: 9463410
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo.
Matsukawa A; Lukacs NW; Standiford TJ; Chensue SW; Kunkel SL
J Immunol; 2000 Feb; 164(4):1699-704. PubMed ID: 10657613
[TBL] [Abstract][Full Text] [Related]
19. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism.
Chiaramonte MG; Hesse M; Cheever AW; Wynn TA
J Immunol; 2000 Jan; 164(2):973-85. PubMed ID: 10623847
[TBL] [Abstract][Full Text] [Related]
20. A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists.
Joshi AD; Raymond T; Coelho AL; Kunkel SL; Hogaboam CM
J Leukoc Biol; 2008 Feb; 83(2):314-24. PubMed ID: 18029396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
